We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands ...
So what does it take for a master perfumer to develop distinctive and classic scents? Yahoo Life Shopping delves into his thoughts, from ideation to getting his perfumes on the shelves. We also asked ...
One stock that might be an intriguing choice for investors right now is Akero Therapeutics, Inc. AKRO. This is because this security in the Medical - Biomedical and Genetics space is seeing solid ...
Hosted on MSN
Does Akero Therapeutics (AKRO) Have the Potential to Rally 59.14% as Wall Street Analysts Expect?
Akero Therapeutics, Inc. (AKRO) closed the last trading session at $48.12, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
On Monday, Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results from SYMMETRY Phase 2b study evaluating the efficacy and safety of its lead product candidate ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best ...
) has been revised to $64.26 / share. This is a decrease of 15.18% from the prior estimate of $75.76 dated September 27, 2025. The price target is an average of many targets provided by analysts. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results